Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Rituximab may cause skin issues, but baricitinib can help improve them.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Oral tofacitinib successfully treated total body hair loss in one patient.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

A group has developed therapies that show promise for treating cancer and various other conditions.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Nanoparticle systems make cancer treatment less toxic.